Assessment of ROP Neonates



This chapter is about assessment of ROP neonates. The correct assessment of plus disease and of zone I or zone II is crucial for determining the correct timing and choice of treatment.


ROP Plus disease Zone I Zone II 


  1. 1.
    Austeng D, Källen KB, Ewald UW, Wallin A, Holmström GE. Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden. Br J Ophthalmol. 2010;94(9):1136–9.CrossRefGoogle Scholar
  2. 2.
    Holmström G, Tornqvist K, Al-Hawasi A, Nilsson Å, Wallin A, Hellström A. Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2018 Mar;96(2):142–8.CrossRefGoogle Scholar
  3. 3.
    Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603–15.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.OphthalmologyUniversity of Uppsala OphthalmologyUppsalaSweden
  2. 2.Department of OphthalmologySamsung Medical Center, Sungkyunkwan UniversitySeoulSouth Korea

Personalised recommendations